Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archive

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Sunday, November 18, 2012

Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer



Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer


Conclusions

Treatment-related toxicities and complications were common in women with ovarian cancer who received IP chemotherapy. Use of IP chemotherapy results in multiple clinical encounters, such as outpatient clinic visits and inpatient admissions. Nursing is a critical part of the interdisciplinary approach in caring for women treated with IP chemotherapy. Interdisciplinary teams with high levels of knowledge and skills related to IP chemotherapy administration are needed to manage treatment-related toxicities and complications, and support multiple clinical encounters during treatment.

0 comments :

Post a Comment

Your comments?